Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pegfilgrastim (L03Aa13) Within The Framework Of A So-Called Open-House Model.
Deadline - Nov 30, 2026
GT reference number - 99609319
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 99609319
Document Type - Tender Notices
Description - Description: Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient pegfilgrastim (L03AA13) within the period from February 1, 2025 t o January 31, 2027 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list according to Section 35 Paragraph 5a SGB V (medicines for children) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Pegfilgrastim (L03AA13) im Rahmen eines sogenannten O
Gt Ref Id - 99609319
Deadline - Nov 30, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database